CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Tasty&Healthy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05211518
NCT05211518N/ACompleted

Preventing IBD Onset in Individuals at Risk

Shaare Zedek Medical Center·interventional·Posted Jan 27, 2022·Updated Mar 27, 2026

In Brief

A clinical study evaluating Tasty&Healthy and Habitual diet for Inflammatory Bowel Diseases. Completed, enrolled 29 participants across 1 site.

Detailed Summary

The goal of this study is to explore in a cross over randomized controlled trial, the ability of the Tasty\&Healthy dietary intervention (NCT04239248) to alter the parameters associated with future risk of developing Chron's disease (CD) using First Degree Relatives of patients with Crohn's disease, including subjects identified in the Genetic Environmental Microbiome (GEM) Study as having a high-risk score. Specifically, the investigators aim to determine if the Tasty\&Healthy dietary intervention can decrease the overall GEM Risk Score (GRS) and/or to alter the individual biological parameters that contribute to this score. The investigators hypothesize that the Tasty\&Healthy dietary approach will alter the risk of CD as reflected by a decrease in the GRS.

Study Details

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 27, 2022
Enrollment StartMay 4, 2021
Primary CompletionJan 15, 2026
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 4.4 years ago

Interventions

Tasty&Healthyother

exclude pro-inflammatory dietary components

Habitual dietother

subjects will continue their habitual diet.